Non-small cell lung cancer molecular subtypes and vulnerability to immunotherapy treatment combinations

Journal:

Nature Communications

Published:

2025-12-03

DOI:

10.1038/s41467-025-66803-8

Affiliations:

8

Authors:

20

Go to article

Institutions	Authors	Share
Genentech, Inc., United States of America (USA)	14.000000 14.000000	0.70
AdventHealth, United States of America (USA)	1.000000	0.05
Airway Research Center North (ARCN), Germany	1.000000	0.05
IRCCS Regina Elena National Cancer Institute (IRE), Italy	1.000000	0.05
Rocky Mountain Cancer Centers, The US Oncology Network, United States of America (USA)	1.000000	0.05
Hoffmann-La Roche Ltd., Canada	1.000000	0.05
Assistance Publique-Hopitaux de Marseille (AP-HM), France	0.500000	0.03
Institute Gustave-Roussy (IGR), France	0.500000	0.03

Interested in Oncology and Carcinogenesis?